Ojinnaka Chinedum O, McClellan David A, Weston Cynthia, Pekarek Katie, Helduser Janet W, Bolin Jane N
Department of Health Policy and Management, Texas A&M Health School of Public Health, College Station, TX 77843-1266, USA.
Department of Clinical and Translational Medicine, College of Medicine, Texas A&M University, 2900 E.29th Street, Bryan, TX 77803, USA; Texas A&M Physicians Family Residency, Texas A&M University, 2900 E.29th Street, Bryan, TX 77803, USA.
Prev Med Rep. 2017 Jan 16;5:257-262. doi: 10.1016/j.pmedr.2017.01.005. eCollection 2017 Mar.
Two human papillomavirus (HPV) vaccines are available and can prevent 98% of HPV 16 and 18 infections. This study aimed to explore determinants of 1) HPV vaccine awareness among a cohort of low-income women participating in a cancer prevention program in Central Texas and compare them to United States residents; 2) determinants of healthcare providers' discussion of HPV vaccine among female residents of the United States. Bivariate and multivariable analysis of HPV vaccine awareness using survey data (n = 359) collected between 2014 and 2016 in Central Texas, and the Health Information and Nutrition Survey (HINTS) data which is a nationally representative dataset (unweighted n = 1214) collected in 2013 were conducted. Bivariate and multivariable regression analyses of healthcare providers' discussion of the HPV vaccine using the HINTS survey data were also conducted. Compared to non-Hispanic Whites, there was a decreased likelihood of HPV vaccine awareness among non-Hispanic Blacks (OR = 0.50; 95% CI = 0.28-0.90) and Hispanics (OR = 0.55; 95% CI = 0.30-0.99) in the grant funded program, as well as non-Hispanic Blacks (OR = 0.28; 95% CI = 0.14-0.58) and Hispanics (OR = 0.22; 95% CI = 0.12-0.41) in the HINTS data. There was also a decreased likelihood of healthcare providers discussing the HPV vaccine with respondents who were 35-49 years (OR = 0.50; 95% CI = 0.30-0.84), 50-64 years (OR = 0.26; 95% CI = 0.14-0.49) or ≥ 65 years compared to those who were 18-34 years among the HINTS data respondents. Interventions to increase HPV awareness among non-Hispanic Blacks and Hispanics, as well as encourage healthcare providers' discussion of the HPV vaccination during patient encounters regardless of the patient's age are needed.
有两种人乳头瘤病毒（HPV）疫苗可供使用，它们可以预防98%的HPV 16和18感染。本研究旨在探讨以下因素：1）在德克萨斯州中部参与癌症预防项目的低收入女性队列中HPV疫苗知晓率的影响因素，并将她们与美国居民进行比较；2）美国女性居民中医疗服务提供者对HPV疫苗讨论情况的影响因素。利用2014年至2016年在德克萨斯州中部收集的调查数据（n = 359）以及2013年收集的具有全国代表性的数据集健康信息与营养调查（HINTS）数据（未加权n = 1214），对HPV疫苗知晓率进行了双变量和多变量分析。还利用HINTS调查数据对医疗服务提供者对HPV疫苗讨论情况进行了双变量和多变量回归分析。与非西班牙裔白人相比，在该资助项目中，非西班牙裔黑人（OR = 0.50；95%CI = 0.28 - 0.90）和西班牙裔（OR = 0.55；95%CI = 0.30 - 0.99）的HPV疫苗知晓率较低，在HINTS数据中，非西班牙裔黑人（OR = 0.28；95%CI = 0.14 - 0.58）和西班牙裔（OR = 0.22；95%CI = 0.12 - 0.41）的知晓率也较低。在HINTS数据的受访者中，与18 - 34岁的受访者相比，医疗服务提供者与35 - 49岁（OR = 0.50；95%CI = 0.30 - 0.84）、50 - 64岁（OR = 0.26；95%CI = 0.14 - 0.49）或≥65岁的受访者讨论HPV疫苗的可能性也较低。需要采取干预措施，以提高非西班牙裔黑人和西班牙裔对HPV的知晓率，并鼓励医疗服务提供者在患者就诊时讨论HPV疫苗接种情况，而不考虑患者的年龄。
